We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Eurofins Scientific SE | EU:ERF | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.06 | -1.99% | 52.12 | 51.94 | 52.26 | 53.18 | 51.86 | 53.08 | 753,707 | 16:40:00 |
From Jun 2019 to Jun 2024
PARIS (Agefi-Dow Jones)--Le laboratoire d'analyses pharmaceutiques Eurofins a annoncé mercredi avoir levé pour 600 millions d'euros d'obligations à échéance au 17 juillet 2026. Ces obligations, libellées en euros, portent un taux fixe annuel de 3,875%. Elles permettront de refinancer de manière proactive deux séries d'obligations d'un montant de 500 millions d'euros chacune, devant arrriver à échéance en janvier 2022 et en janvier 2023, a précisé le groupe dans un communiqué. (fschott@agefi.fr) ed: FRB
Agefi-Dow Jones The financial newswire
(END) Dow Jones Newswires
May 06, 2020 13:00 ET (17:00 GMT)
1 Year Eurofins Scientific Chart |
1 Month Eurofins Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
